Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (271-280 of 437) with videos related to

Pageof 44
Sort By:
Journal for Immunotherapy of Cancer|September 17, 2020
Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cellsSemjon Willier, Johannes Raedler, Franziska Blaeschke, et al.
Klinische Padiatrie|November 9, 2010
Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantationT C Bittner, U Pannicke, E D Renner, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
ABT-299, a potent antagonist of platelet activating factorJ B Summers, D H Albert, S K Davidsen, et al.
Journal of Clinical Immunology|August 24, 2023
Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease CarriersChristo Tsilifis, Tuulia Torppa, Eleri J Williams, et al.
Public Health Action|September 25, 2015
Impact of mycobacterial culture among HIV-infected adults with presumed TB in Uganda: a prospective cohort studyF C Semitala, L H Chaisson, S den Boon, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
Journal of Clinical Microbiology|February 15, 2008
Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalenceO J Strauss, R M Warren, A Jordaan, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2011
A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma modelYanping Luo, Fang Jiang, Todd B Cole, et al.
Nature Communications|November 9, 2019
Hydrothermal alteration of andesitic lava domes can lead to explosive volcanic behaviourMichael J Heap, Valentin R Troll, Alexandra R L Kushnir, et al.
Leukemia & Lymphoma|January 28, 2012
Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemiaEunice S Wang, Karen Yee, Liang Piu Koh, et al.
Pageof 44

Showing results (271-280 of 437) with videos related to

Sort By:
Pageof 44
Journal for Immunotherapy of Cancer|September 17, 2020
Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cellsSemjon Willier, Johannes Raedler, Franziska Blaeschke, et al.
Klinische Padiatrie|November 9, 2010
Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantationT C Bittner, U Pannicke, E D Renner, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
ABT-299, a potent antagonist of platelet activating factorJ B Summers, D H Albert, S K Davidsen, et al.
Journal of Clinical Immunology|August 24, 2023
Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease CarriersChristo Tsilifis, Tuulia Torppa, Eleri J Williams, et al.
Public Health Action|September 25, 2015
Impact of mycobacterial culture among HIV-infected adults with presumed TB in Uganda: a prospective cohort studyF C Semitala, L H Chaisson, S den Boon, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
Journal of Clinical Microbiology|February 15, 2008
Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalenceO J Strauss, R M Warren, A Jordaan, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2011
A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma modelYanping Luo, Fang Jiang, Todd B Cole, et al.
Nature Communications|November 9, 2019
Hydrothermal alteration of andesitic lava domes can lead to explosive volcanic behaviourMichael J Heap, Valentin R Troll, Alexandra R L Kushnir, et al.
Leukemia & Lymphoma|January 28, 2012
Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemiaEunice S Wang, Karen Yee, Liang Piu Koh, et al.
Pageof 44